Combination of Capmatinib + Spartalizumab in Advanced Oesogastric Adenocarcinoma

Clinical trial NCT05135845 · SUSPENDED

Trial details

NCT number: NCT05135845
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Oesophageal Adenocarcinoma Gastric Adenocarcinoma

Start date: 2022-03-22
Primary completion: 2023-04-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.